pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Sep 1·1 min read
save

House passes stopgap bill to block White House plan for political control of federal research grants

Sep 1, 2026·read at STAT ↗RegulatoryNeutral

The House approved a temporary funding measure that blocks a White House proposal to let political appointees oversee federal research grants.

The measure passed 370‑48 and mirrors a Senate bill passed a month earlier, now awaiting the president’s signature.

The funding bill only extends government operations until Dec. 11, after which the ban on the grant‑control policy will expire.

The action aims to prevent politicization of research funding ahead of the midterm elections and avoid a shutdown.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: House votes to temporarily block Trump plan to politicize federal grants”

read at STAT ↗
471 words · retrieved Sep 1
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Ultragenyx Pharmaceutical Inc.
topics
ImmunologyOncologyRare DiseaseVaccine

related stories

  • 4d agoCaribou layoffs could wipe out 90% of staffBioSpace
  • Sep 28Opinion: AI is eroding the barriers that kept biological weapons rareSTAT
  • Sep 22Opinion: Former FDA commissioners: Heidi Overton has an opportunity to strengthen the FDASTAT
  • Sep 17Chutes & Ladders—Legend poaches Novartis vet to boost commercial potentialFierce Biotech
  • Sep 14After a brief storm of political headwinds, mRNA is back with strong momentumBioSpace